Empresa Clover Biopharmaceuticals, Ltd.
Acciones
2197
KYG2280A1076
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,37 HKD | +7,25 % | +12,12 % | -40,32 % |
Resumen de negocios
Número de empleados: 387
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Vaccines
100,0
%
| 0 | nan % | 43 | 100,0 % | - |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 0 | nan % | 43 | 100,0 % | - |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Joshua Liang
CEO | Chief Executive Officer | - | 25/12/20 |
Aileen Wang
DFI | Director of Finance/CFO | - | 01/03/21 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 56 | 03/02/21 |
Wang Xiaoyan
SEC | Corporate Secretary | - | 31/03/23 |
Lily Yang
HRO | Human Resources Officer | - | 01/05/21 |
Liong Ho Chua
PRN | Corporate Officer/Principal | 60 | 27/04/22 |
Xiao Bing Li
PRN | Corporate Officer/Principal | 56 | 27/07/20 |
Hing Ling Chau
SEC | Corporate Secretary | 49 | 22/12/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jeffrey Farrow
BRD | Director/Board Member | 62 | 19/04/21 |
Xiao Dong Wang
BRD | Director/Board Member | 61 | 16/03/21 |
Xiao Bin Wu
BRD | Director/Board Member | 62 | 19/04/21 |
Donna Ambrosino
BRD | Director/Board Member | 72 | 17/06/22 |
Ralf Clemens
BRD | Director/Board Member | 71 | 17/06/22 |
Thomas Leggett
BRD | Director/Board Member | 47 | 19/04/21 |
Peng Liang
CHM | Chairman | 63 | 31/10/18 |
Joshua Liang
CEO | Chief Executive Officer | - | 25/12/20 |
Xiang Liao
BRD | Director/Board Member | 59 | 19/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 1 296 995 429 | 634 387 467 ( 48,91 %) | 0 | 48,91 % |
Información de la empresa
Clover Biopharmaceuticals Ltd.
49F, Park Place 1598-1601 West Nanjing Road
200010, Shanghai
+
http://www.cloverbiopharma.comSector
Ventas por región
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-40,32 % | 57,19 M | |
-1,65 % | 104 mil M | |
+6,75 % | 97,47 mil M | |
+5,71 % | 22,25 mil M | |
-12,60 % | 21,68 mil M | |
-9,70 % | 18,2 mil M | |
-39,98 % | 17,02 mil M | |
-10,17 % | 16,36 mil M | |
+6,12 % | 14,39 mil M | |
+35,47 % | 12,37 mil M |
- Bolsa de valores
- Acciones
- Acción 2197
- Empresa Clover Biopharmaceuticals, Ltd.